To include your compound in the COVID-19 Resource Center, submit it here.
Infinity began a dose-escalation, U.S. Phase Ib/II trial to evaluate 450 mg/m 2 IV retaspimycin weekly in
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury